Scilex Holding Company (SCLX)

NASDAQ: SCLX · Real-Time Price · USD

8.12

+0.11 (1.37%)

Feb 20, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Development of Non-Opioid Products	56.59M	46.74M	38.03M	31.32M	23.56M
Development of Non-Opioid Products Growth	21.07%	22.90%	21.45%	32.92%	12.01%
Total	56.59M	46.74M	38.03M	31.32M	23.56M
Total Growth	21.07%	22.90%	21.45%	32.92%	12.01%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	56.59M	46.74M	38.03M	31.32M	23.56M
United States Growth	21.07%	22.90%	21.45%	32.92%	12.01%
Total	56.59M	46.74M	38.03M	31.32M	23.56M
Total Growth	21.07%	22.90%	21.45%	32.92%	12.01%

Source: S&P Global Market Intelligence.